In addition to the interaction between mdm2 and p53, posttranslational modifications of p53 protein, including multiple 1 To whom correspondence should be addressed Email: xas0@cdc.gov phosphorylations and acetylations, also play a key role in regulating p53 activity (14)(15)(16) Recently, several groups reported the acetylation of the p53 and acetylated at Ser15 and Lys382, respectively. The C-terminal domain by histone acetyltransferases p300, CBP phosphorylation levels at either Ser20 or Ser392 did not (CREB binding protein) and PCAF (p300/CBP-associated show any significant alterations. Since previous studies factor) (27) (28) (29) . N-terminal phosphorylation is responsible for report that it is Ser20 and not Ser15 phosphorylation that both enhanced transactivation activity and the dissociation of contributes to mdm2 dissociation from p53, the results mdm2. Modifications at the C-terminal end are associated obtained from the current investigation suggest a different with an increase in sequence-specific DNA binding ability. mechanism: Ser15 instead of Ser20 may play a key role in Phosphorylation and acetylation events have a synergistic the dissociation of mdm2 in response to Cr(VI). Erk, a effect on the activation of p53 protein.
Introduction carcinogenesis are not fully understood, the reactive metabolic The p53 tumor suppressor protein plays an important role in products of Cr(VI), including reactive oxygen species (ROS), protecting cells from fatal genetic injury (1,2). Mutational Cr(V) and Cr(IV), are considered to play major roles in inactivation of p53 protein has been found to be involved in the carcinogenic process (35) (36) (37) (38) (39) (40) . Previous work from our various cancers in humans and experimental animals (2). A laboratory showed that Cr(VI) activates p53 protein via variety of mutations in the p53 gene have been reported in hydroxyl radical-mediated reactions (36) . In the present Ͼ50% of human cancers, suggesting a crucial role for p53 study, we extend our investigation to elucidate the possible protein in maintaining normal cell growth (2,3). mechanisms of activation of p53 induced by Cr(VI). Normally, p53 has a very short half-life and protein levels are low (4). A lengthening of the half-life and rapid accumulation of Materials and methods p53 protein were observed in response to a variety of stimuli, such as UV light, γ radiation, hypoxia and nucleotide deprivaMaterials tion (5-8). A key player in this modulation is the murine Sodium dichromate (Na 2 Cr 2 O 7 ) was purchased from Aldrich (Milwaukee, double minute-2 (mdm2) proto-oncoprotein. mdm2 binds to WI). Cycloheximide, actinomycin D and p38 inhibitor (SB 202190) were purchased from Calbiochem (La Jolla, CA). MEK1 inhibitor, PD 98059, was p53 within its N-terminal transactivation domain, blocks its purchased from New England Biolabs (Beverly, MA).
transcriptional activity, shuttles p53 out of the nucleus and mediates p53 degradation by ubiquitin-protease (9-13). Since
Cell culture the expression of mdm2 is regulated directly by the p53
A human lung epithelial cell line (A549 cells) was obtained from American Type Culture Colletion (ATCC) (Rockville, MD). The cells were maintained in a nutrient mixture (Kaighn's Modification) medium (F-12K) (Gibco BRL, Abbreviations: ATM, ataxia telangiectasia mutated; cdk, cyclin-dependent kinase; CHX, cycloheximide; DNA-PK, DNA-dependent protein kinase; Grand Island, NY) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine and 1000 U/ml penicillin/streptomycin. The cells were cultured in Erk, extracellular-signal regulated kinase; FBS, fetal bovine serum; JNK, c-jun N-terminal kinase; MAP, mitogen-activated protein; mdm2, murine double 75 cm 2 cell culture flasks and trypsinized with 0.25% trypsin/EDTA for plating and passaging. minute-2; PKC, protein kinase C; ROS, reactive oxygen species.
Luciferase assay Human lung epithelial A549 cells (3ϫ10 5 ) suspended in 1 ml 10% FBS F-12K medium were seeded into each well of a 6-well plate. Following incubation at 37°C for 24 h, the cells were transiently transfected with 1 µg reporter plasmid and 1 µg β-gal plasmid in reduced-serum medium. The cells were incubated overnight, washed and fresh 10% FBS F-12K medium was added. The cells were exposed to various treatments after an additional 24 h of culture. The cells were then extracted with 400 µl reporter lysis buffer at 4°C for 2 h. The luciferase activity was measured with 80 µl cell lysate, using a Monolight luminometer, Model 3010 (Analytical Luminescence Laboratory, Sparks, MD). β-Gal activity was determined as described previously (41) . The results are expressed as relative p53 activity compared with controls after normalizing by β-gal activity.
Western blot
The whole cell lysate was used for western blot analysis. Aliquots of 2ϫ10 5 cells were cultured in each well of 6-well plates to 95% of confluency. After treatment, the cells were washed once with ice-cold PBS and extracted with 100 µl SDS-sample buffer. The extracts were then sonicated to shear DNA and reduce the viscosity. A 20 µl aliquot of lysate was heated to 95°C for 5 min and microcentrifuged for another 5 min. Proteins were electrophoretically separated on 10% Tris-glycine gels (Novex, San Diego, CA) and were transferred to nitrocellulose membrane (Schleicher & Schuell, Keene, NH). The membrane was treated with a blocking buffer [Tris-buffered saline Tween (TBS-T) containing 5% non-fat milk] for 1 h and exposed to primary antibody at 4°C overnight. The membrane was rinsed and incubated with a 1:2000 dilution of secondary antibody for 1 h. The membrane was then washed with TBS-T and antibody binding sites were visualized by ECL western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ). P53 mouse monoclonal antibody (DO-1) and mdm2 mouse monoclonal antibody were from Santa Cruz Biotechnology (Santa Cruz, CA); phosphop53, phospho-p38 kinase (Thr180/Tyr182) and phospho-Erk kinase (Thr202/ of 6-well plates to 95% of confluency. After 3 h of treatment with Cr(VI) at Immunoprecipitation various concentrations, the cells were collected and whole cell lysates were Aliquots of 2ϫ10 5 cells were cultured in each well of 6-well plates to 95% obtained. The p53 protein levels were determined by western blot, using of confluency. After treatment, the cells were washed once with ice-cold PBS specific antibodies for p53 protein. (b) Luciferase assay for Cr(VI)-induced and collected in 100 µl PBS. After addition of 100 µl 2ϫ reducing buffer p53 activation. Human lung epithelial A549 cells (3ϫ10 5 ) suspended in (0.125 M Tris, pH 6.8, 20% glycerin, 2% SDS and 10% 2-mercaptoethanol), the 1 ml 10% FBS F-12K medium were seeded into a 6-well plate. After being extracts were boiled at 95°C for 5 min and 500 µl TNT buffer (20 mM Tris, incubated at 37°C in a humidified atmosphere of 5% CO 2 for 24 h, the cells pH 7.4, 0.2 M NaCl and 1% Triton 100) was added. The cell lysate, 20 µl were transiently transfected with a p53-luciferase reporter plasmid and a Recin/TNT (1:10) and 10 µg antibody were incubated at 4°C overnight on a β-gal plasmid in reduced-serum medium. The cells were incubated rotor mixer. Recin was spun down and washed with TNT buffer followed by overnight, washed, added to fresh 10% FBS F-12K medium and incubated boiling with 20 µl reducing buffer for 5 min. The supernatant was collected for 24 h. The cells were exposed to Cr(VI) at various concentrations for for western blot analysis.
3 h, washed, added to fresh F-12K medium and incubated overnight. The p53 activity was measured by luciferase activity assay as described in the Materials and methods. Results are presented as relative p53 induction
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compared with the untreated control cells (means and standard deviation of three separated experiments). Asterisks indicate a significant increase from
Cr(VI)-induced p53 activation
control (P Ͻ 0.05), using Student t-test for data analysis.
Human lung epithelial A549 cells were used to study induction of p53 activation by Cr(VI). The cells were incubated with Transcription is not an important factor for p53 activation Cr(VI) at different concentrations for 3 h. P53 protein level by Cr(VI) was analyzed in the whole cell lysates. As shown in Figure  1a , p53 protein levels increased following exposure to Cr(VI)
In general, protein expression can be regulated at several different levels: the transcriptional level (mRNA), the translacompared with control. Increasing the Cr(VI) dosage had little effect on the p53 protein level.
tional level (protein synthesis) or the post-translational level (protein modification such as phosphorylation and acetylation). Since p53 is a transcription factor, its transactivation activity can be determined by a luciferase assay. Briefly, the cells were To investigate whether p53 protein activation is due to an increased mRNA level, actinomycin D (AMD), an inhibitor co-transfected with p53-luciferase reporter plasmid and β-gal plasmid, and incubated with different concentrations of Cr(VI) of transcription, was used to pre-treat cells before the 3 h incubation with Cr(VI). As is shown from western blots, for 3 h. After washing the cells, fresh F-12K medium supplemented with 10% FBS was added. The cells were then inhibition of transcription did not decrease levels of p53 protein (Figure 2a , lanes 3 and 6). Addition of cycloheximide (CHX), incubated at 37°C overnight. P53 activity was analyzed by luciferase assay as described in Materials and methods.
an inhibitor of protein synthesis, dramatically reduced levels of p53 protein ( Figure 2a , lanes 2 and 5). These results suggest Figure 1b shows the results of the luciferase assay for p53 activity. P53 activity increased following exposure to Cr(VI).
that the Cr(VI)-induced increase in p53 protein level is not due to an increase in transcription. Increasing the Cr(VI) concentration up to 50 µM enhanced p53 activity. Increasing Cr(VI) concentration further resulted
To further confirm the above conclusion, a p53-promoter luciferase plasmid (a generous gift from Dr Finian Martin, in a slightly lower p53 activation, possibly due to Cr(VI)-induced apoptosis.
University College Dublin, Ireland), which can be used to Percentage of p53 protein level at different times based on the quantitation of (a).
Fig. 2. Transcription is not a major factor in p53 activation. (a) A549 cells
were pre-treated with 10 µg/ml cycloheximide (CHX) or 1 µg/ml actinomycin D (AMD) for 30 min, followed by incubation with or without 50 µM Cr(VI) for 3 h. The whole cell lysates were collected for western blot analysis, using a specific p53 antibody. (b) Luciferase assay for p53 promoter activity. A549 cells were transiently transfected with p53-promoter luciferase plasmid. Then the cells were exposed to various Fig. 4 . Phosphorylation and acetylation of p53 induced by Cr(VI). A549 concentrations of Cr(VI) for 3 h, washed, added to fresh F-12K medium and cells were incubated with various concentrations of Cr(VI) for 3 h. The incubated overnight. The p53 activity was measured by the luciferase whole cell lysates were collected for western blot analysis using specific activity assay. UVC light was used as a positive control. Results are antibodies for p53 protein, Ser15 and Ser392 phospho-p53 and Lys382 presented as relative p53 promoter induction compared with the untreated acetylated p53 protein, respectively. UVC light was used as a positive control cells (means and standard deviation of three separate assays).
control. Asterisks indicate a significant increase from control (P Ͻ 0.05), using Student t-test for data analysis. With the addition of Cr(VI), Ser15 phosphorylation increased The results obtained from both western blot and luciferase and peaked at 50 µM Cr(VI) exposure. Acetylation of Lys382 assays demonstrate that p53 activation is due to enhanced at the C-terminus of p53 protein exhibited a similar doseprotein synthesis, rather than increased gene expression. dependent pattern, but with a peak at 20 µM Cr(VI). In Post-translational modifications are important for p53 contrast, phosphorylation of N-terminal residue Ser20 and activation by Cr(VI) C-terminal residue Ser392 showed little change in response to stimulation with Cr(VI) (Figure 4 ). In addition to protein synthesis, protein degradation is also an important factor in regulating total protein levels. CHX was Another major factor that influences the stability of p53 protein is the binding of p53 with mdm2. In the cytoplasm, utilized to investigate the rate of degradation of p53 protein with or without Cr(VI) stimulation. A549 cells were exposed the binding of mdm2 to the N-terminus of p53 promotes the degradation of p53. Since we observed that the rate of p53 to Cr(VI) for 3 h followed by addition of CHX. At different time points after cessation of protein synthesis, whole cell degradation was reduced upon stimulation with Cr(VI), the possible involvement of mdm2 in this process was investigated. lysates were collected to perform western blots. In normal cells, the p53 half-life was approximately 1 h. After stimulation A549 cells were incubated with Cr(VI) for 3 h and then collected for immunoprecipitation by p53 antibody. The bindwith Cr(VI), the rate of degradation of p53 protein was reduced dramatically with no significant decrease in protein levels even ing of mdm2 was determined by western blot analysis. As shown in Figure 5 , the binding of mdm2 to p53 dramatically at 4 h (Figure 3) , indicating enhanced stability of the p53 protein after Cr(VI) stimulation.
decreased at a concentration of 50 µM Cr(VI) and disappeared at 100 µM Cr(VI). It is generally believed that post-translational modifications, including phosphorylation and acetylation, play a role in These results suggest that phosphorylation of Ser15, . A549 cells were incubated with various concentrations of Cr(VI) for 3 h, followed by immunoprecipitation with a specific p53 antibody. Western blot analysis was performed, using a specific antibody for mdm2 protein. protein. 30 min, followed by incubation with or without 50 µM Cr(VI) for 3 h. The whole cell lysates were collected for western blot, using specific antibody
Discussion
for phospho-Ser15 p53 antibody.
The present study shows that post-translational modifications, including phosphorylation at the N-terminus, acetylation at the acetylation of Lys382 and disassociation of mdm2 are jointly C-terminus and segregation of mdm2, play a central role in responsible for p53 activation induced by Cr(VI).
Cr(VI)-induced p53 activation.
Erk is important in the phosphorylation of Ser15
Previous studies from our group have demonstrated that after exposure to Cr(VI), p53 protein is activated at the protein It has been reported that MAP kinase family members are involved in p53 phosphorylation induced by UV light. P38 level and via enhancement of both sequence-specific DNA binding ability and transactivation ability (26) . In the present kinase was found to phosphorylate Ser392 of p53 protein, and c-jun N-terminal kinase (JNK) was reported to associate with study, we further investigated the molecular mechanisms of p53 activation. Several groups have reported that increased p53 directly and stabilize the protein (26, 43) . To further understand the mechanisms of p53 activation by Cr(VI), mRNA expression or transcriptional activation was important for p53 activation (44-46). In our experiments, the addition we examined the possible roles of MAP kinase on p53 phosphorylation. Both p38 kinase and extracellular-signal of an inhibitor of transcription, actinomycin D, did not show any inhibitory effects on p53 activation. Consistent with this regulated kinase (Erk) can be activated by Cr(VI) in a dose and time dependent manner (Figure 6a) . Two chemical observation, the luciferase assay from cells transfected with p53 promoter-luciferase reporter plasmid demonstrates that inhibitors, PD98059 (PD), a MEK1 inhibitor that is able to abolish Erk activity, and SB202190 (SB), a p38 kinase inhibitor, p53 activation by Cr(VI) was not due to transcriptional activation. were pre-incubated with cells followed by Cr(VI) exposure. As shown in Figure 6b , inhibition of p38 kinase activity did P53 exists as a tetramer and rapidly degrades in normal cells. The degradation is mediated by proto-oncoprotein mdm2. not have any effect on Ser15 phosphorylation. In contrast, inhibition of Erk significantly decreased the phosphorylation
The prerequisite for mdm2 to promote p53 degradation is its direct binding to the N-terminus of p53 protein. In addition to of Ser15. In addition to the role of Erk in phosphorylation of the p53 Ser15 site, we examined the effects of Erk on the p53 mediating p53 degradation, the binding of mdm2 also blocks the transactivation ability of p53. Therefore, breaking the p53-transactivation ability by luciferase assay. As shown in Figure  7 , addition of PD significantly reduced p53 activation induced mdm2 interaction is a major mechanism to stabilize p53. Mdm2 protein immunoprecipitated with p53 decreased to by Cr(VI). The results suggest that Erk plays an important undetectable levels with Cr(VI) stimulation, demonstrating the the damaged cells. Since these two processes have a crucial role in protecting cells from permanent genetic damage, dissociation of mdm2 from p53 induced by Cr(VI). The dissociation of mdm2 may be one explanation for the observed which is mediated by p53, alterations in these pathways can contribute to cancer development. Therefore, understanding dramatic reduction in rate of p53 degradation after Cr(VI) stimulation.
the mechanisms of p53 activation is essential for the understanding of the overall carcinogenic process induced not only One of the factors inducing disassociation of mdm2 from p53 is phosphorylation of p53 protein at its N-terminus. Nby Cr(VI), but also by other chemical and particle carcinogens.
In conclusion, post-translational modifications, including terminal phosphorylation has been reported to activate the transactivation ability of p53 (22) . It is generally believed that Ser15 phosphorylation, Lys382 acetylation and mdm2 dissociation, play a crucial role in the process of Cr(VI)-the phosphorylation sites close to or inside the mdm2 binding site (residues 18-23), such as Ser15 and Ser20, are capable of induced p53 activation. Erk, and not p38 kinase, is responsible for the phosphorylation of Ser15 induced by Cr(VI). interfering with the association between mdm2 and p53. However, recent reports from several groups suggest that phosphorylation of the Ser15 site only affects p53's transAcknowledgements activation ability while Ser20 phosphorylation is believed to
We appreciate the suggestions and comments from Vince Castranova, Fei Chen, mediate the dissociation of mdm2 from p53 and the stabilization Min Ding, and Chuanshu Huang, Murali Rao, Val Vallyathan, and Jianping of p53 (47) (48) (49) . In the present study, we find reduced mdm2 contradictory results. For example, p38 kinase was considered and apoptosis, which are responsible for repairing or removing
